Stony Brook, NYNCT06693011Now EnrollingIRB Ready

Cerebral Aneurysms Clinical Trial in Stony Brook, NY

Access cutting-edge cerebral aneurysms treatment through this clinical trial at a research site in Stony Brook. Study-provided care at no cost to qualified participants.

Sponsored by Cerus Endovascular, Inc.

Quick Self-Assessment

See if you qualify for this Stony Brook location

Preparing your pre-screening questions…

Expert Care in Stony Brook

Access cerebral aneurysms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cerebral aneurysms treatment provided free

Apply for This Stony Brook Location

Check if you qualify for this cerebral aneurysms clinical trial in Stony Brook, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stony Brook

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stony Brook site if eligible
  4. 4Begin participation

About This Cerebral Aneurysms Study in Stony Brook

The goal of this clinical trial is to collect additional data to demonstrate if the Contour Neurovascular System (CNS) is a safe and effective treatment of wide-necked, saccular, intracranial aneurysms. Participants will: Undergo treatment with the Contour Neurovascular System Complete follow-up visits at 1month, 12months, and 24 months, following their procedure Report any adverse events to their study team

Sponsor: Cerus Endovascular, Inc.

Who Can Participate

Inclusion Criteria

Patient is 18-75 years of age at the time of screening.
Patient has a single ruptured or unruptured IA requiring treatment. If the patient has an additional IA requiring treatment, the additional IA must not require treatment within 60 days after the index procedure.
The target IA must have the following characteristics:
Saccular morphology
Located at a bifurcation in the anterior or posterior circulation
Aneurysm neck diameter between 2 and 10 mm and aneurysm equatorial diameter between 2 and 10.5 mm
Wide-necked, defined as neck size ≥ 4 mm or a dome/neck ratio \< 2
Patient may be treated with Contour without the use of additional implanted devices.
Patient is able to comply with all aspects of the screening, evaluation, treatment, and the post-procedure follow-up schedule.
Patient or legally authorized representative has signed and dated an institutional review board (IRB)/Ethics Committee (EC)-approved written informed consent prior to initiation of any study procedures. FOR PATIENTS WITH UNRUPTURED ANEURYSM
Patient meets the criteria outlined in the "Guidelines for the Management of Patients With Unruptured Intracranial Aneurysms" as published by the AHA/ASA\^6 FOR PATIENTS WITH RUPTURED ANEURYSM
Patient meets the criteria outlined in the "Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association" as published by the AHA/ASA.\^6
Patient must be neurologically stable with Hunt \& Hess Score of I, II or III. (\^6: 6 https://www.ahajournals.org/doi/full/10.1161/STR.0000000000000070)

Exclusion Criteria

Anatomy or physiology considered unsuitable for endovascular treatment with the Contour device by the implanting physician and/or the Patient Selection Committee
Target IA contains other devices/implants (e.g., coils) that could interfere with the correct placement of the Contour device
Subject has a known, untreatable hypersensitivity to contrast dye, iodine, or any component of the treatment device.
Contraindication to anticoagulants or anti-platelet medications
Stenosis of the target IA's parent vessel is \>50%
Anticoagulation medications (e.g., warfarin) that cannot be discontinued
Acute / chronic renal failure (unless on dialysis) or creatinine \> 2.00 mg/dl or \> 182 μmol/L
Vascular disease or other vascular anomaly that precluded the necessary access to the aneurysm for use of the study device.
Clinical, angiographic or computed tomography (CT) evidence of vasospasm, vasculitis, an intracranial tumor (except small meningioma) or any other intracranial vascular malformations on presentation.
Conditions placing them at high risk for ischemic stroke or had exhibited ischemic symptoms such as transient ischemic attacks, minor strokes, or stroke-in-evolution within the prior 60-days.
Any circulatory, neurovascular, cardiovascular, or neurologic conditions that can result in unstable neurological symptoms (e.g., multiple sclerosis, established seizure disorder).
Modified Rankin Scale (mRS) score ≥ 2 prior to presentation or rupture (as applicable).
Subarachnoid hemorrhage (SAH) from a non-index aneurysm or any other intracranial hemorrhage within 90 days.
Physical, neurologic or psychiatric conditions which precluded his/her ability to comply with all aspects of the screening, evaluation, treatment, and the post-procedure follow-up schedule.
Pregnant, breastfeeding or planning pregnancy in the next 2 years
Subject is enrolled in another device or drug study in which participation could confound study results.
Life expectancy of less than 2 years due to an illness or condition other than the index intracranial aneurysm.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stony Brook?

Yes, this clinical trial (NCT06693011) has an active research site in Stony Brook, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cerebral Aneurysms Treatment Options in Stony Brook, NY

If you're searching for cerebral aneurysms treatment options in Stony Brook, NY, this clinical trial (NCT06693011) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stony Brook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cerebral aneurysms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cerebral aneurysms clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Stony Brook, NY

See all multiple sclerosis clinical trials recruiting in Stony Brook — not just this study.

Browse Multiple Sclerosis Trials in Stony Brook →

Browse More Trials by Condition

Multiple Sclerosis TrialsRheumatoid Arthritis TrialsAll Conditions →

Ready to Join in Stony Brook?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stony Brook, NY